At a glance: IGF-1 LR3 is a lab-modified version of insulin-like growth factor 1 (IGF-1), originally made as a cell-culture supplement for laboratories. It is sold online for muscle growth and recovery, but no human clinical trial has ever tested it. It is not FDA-approved, has no compounding status, is banned in sport, and carries real risks including low blood sugar. It is not the same as mecasermin (Increlex), the approved IGF-1 medicine.
What is IGF-1 LR3?
IGF-1 is a hormone made mainly by the liver in response to growth hormone. It drives much of growth hormone's effect on muscle, bone and tissue growth, and it lowers blood sugar in a way similar to insulin.
IGF-1 LR3 ("Long R3 IGF-1") is a synthetic, engineered version. It has one amino acid swapped (an arginine at position 3, the "R3") and an extra chain of amino acids added to one end (the "Long"). These changes make it bind much less to the proteins in blood that normally hold IGF-1 inactive, so more of it is free to act. It was developed for growing cells in laboratory and biotech manufacturing, not as a medicine.
How is it supposed to work?
- Activates IGF-1 receptors on muscle and other cells, switching on growth signaling (the PI3K/AKT pathway) that increases protein building and cell division
- Avoids binding proteins: natural IGF-1 is mostly bound and held in reserve; LR3's changes leave more of it active
- Lasts longer: marketers commonly claim a half-life of 20 to 30 hours. Natural free IGF-1 is cleared in minutes (protein-bound IGF-1 lasts much longer), but there are no human studies measuring how long LR3 actually lasts
- Insulin-like effects: it pushes glucose into cells, which is the source of its low-blood-sugar risk
What the research shows so far
| Type of study | What was found | Strength of evidence |
|---|---|---|
| Cell culture | Strongly stimulates growth of muscle and other cells; this is its main legitimate use | Lab |
| Animal studies | Growth and anabolic effects in rodents; in a mouse cancer-cachexia study it limited muscle loss but accelerated tumor growth | Animal |
| Human trials | None. No study has tested IGF-1 LR3 for muscle, recovery, fat loss or anti-aging in people | None |
| Mecasermin (approved natural-sequence IGF-1) | Effective for children with severe primary IGF-1 deficiency | Strong, but does not apply to LR3 |
Clinic articles often cite studies of natural IGF-1, growth hormone or exercise to support LR3. Those results do not transfer to LR3.
Why it gets attention
- Bodybuilding and performance: promoted for muscle growth, recovery and leanness
- Potency marketing: sold as a stronger, longer-lasting form of a natural growth factor
- Wellness clinics offering it for recovery, healing and anti-aging, often with dosing charts that have no clinical basis
- Easy online availability as a "research chemical"
How it is used
Products are sold as a powder for injection under the skin. Because no human trial exists, there is no established safe or effective human dose, and dosing charts and "cycles" found online are anecdotal. This page does not provide dosing guidance.
What about side effects?
- Low blood sugar (hypoglycemia): the most immediate danger, causing sweating, shakiness, confusion and, in severe cases, seizures or loss of consciousness; especially risky for people using insulin or with diabetes
- Growth signaling and cancer: strong IGF-1 signaling promotes cell growth, and LR3 sped tumor growth in mice. High IGF-1 levels have been linked to higher risk of some cancers. People with cancer or a history of it face serious unstudied risks.
- Fluid retention, swelling and joint pain, and numbness or tingling
- Abnormal tissue growth with long-term use is a theoretical concern, based on what excess growth hormone and IGF-1 do
- Product quality: online products may be mislabeled, underdosed, contaminated or non-sterile
- Pregnancy and breastfeeding: should not be used
Regulatory status
- Not FDA-approved for any use, and not eligible for pharmacy compounding. FDA has issued warning letters over compounded IGF-1 LR3.
- Sold legally only as a laboratory reagent; "research use only" products are not intended for human use.
- Prohibited at all times by the World Anti-Doping Agency, along with IGF-1 and its analogs.
- The only FDA-approved IGF-1 drug is mecasermin (Increlex), approved in 2005 for children with severe primary IGF-1 deficiency. It is a different product, and its dosing and safety data do not apply to LR3.
IGF-1 LR3 vs mecasermin
| IGF-1 LR3 | Mecasermin (Increlex) | |
|---|---|---|
| Structure | Modified: one amino acid swapped plus an added chain | Identical to natural human IGF-1 |
| Original purpose | Laboratory cell-culture supplement | Medicine for severe IGF-1 deficiency |
| Human trials | None | Clinical trials in children |
| US status | Not approved; not compoundable | FDA-approved (2005) |
The bottom line
IGF-1 LR3 is a powerful growth signal that was designed for growing cells in a dish, not for people. There are no human trials, no established dose, and serious risks including dangerous drops in blood sugar and a tumor-growth signal in animal research. It is not approved, not legally compoundable and banned in sport. Anyone concerned about muscle loss, recovery or growth hormone levels should see a clinician; approved, monitored treatments exist for true deficiencies.
Frequently asked questions
What is IGF-1 LR3?
A modified version of insulin-like growth factor 1 (IGF-1). One amino acid is changed and 13 are added, so it binds less to the proteins that normally switch IGF-1 off.
How is IGF-1 LR3 taken?
Laboratory cell culture reagent.
Is IGF-1 LR3 FDA approved?
Not approved; on WADA’s prohibited list.
That means no regulator has reviewed its safety, effectiveness or manufacturing quality for this use.
What has research shown about IGF-1 LR3?
- Cell growth in lab cell cultures, which is its main use.
- Muscle and tissue growth in animal studies.
What side effects have been reported?
- Not characterised in humans
Serious or less common risks are listed in the Side Effects section above.
What is still unknown about its safety?
Most of it. IGF-1 LR3 has not been through the trials that establish long-term safety in people, and products sold online are made by unregulated labs. Independent testing of online peptides has repeatedly found contents that do not match the label.
References
- American Wellness Pharmacy: IGF-1 LR3 explained. View source
- Tucson Wellness MD: IGF-1 LR3 explained, beginner's guide (cites FDA warning letter and mecasermin label). View source
- Superpower: IGF-1 LR3, what it is and what the research shows (animal and cell evidence). View source
- Rite Aid: IGF-1 LR3 status and safety. View source
- Drugs.com: Increlex (mecasermin) FDA approval history. View source
- World Anti-Doping Agency: Prohibited List. View source